Suneva Launches Artefill Acne Scarring Trials

Suneva Medical is launching a multicenter study to investigate the efficacy of its long-term filler Artefill for the treatment of acne scars. The 150-patient prospective study is being conducted at 10 centers throughout the United States. “Acne scarring impacts patients both physicially and emotionally as it is a direct reminder of the issues that affected them during their earlier years. However, there is no permanent solution on the market today to address this widespread cosmetic issue,” said Nicholas Teti, chairman and CEO of Suneva. “We believe Artefill’s unique composition may provide these patients a real solution for what many thought would be a life-long problem.”